1 completed, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Part 2: new trials by email Literature Review of Part 2 trials Research Report on Part 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD AERO-001, AERO-002, AERO-007 - COPD | Phase 1 / Phase 2 | Completed | AeroRx Therapeutics Inc. | 24 | 2025-01-15 | 2025-08-01 |
| Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo Part 1, Part 2 - Mild to Moderate COVID-19 | Phase 2 / Phase 3 | Terminated | Daewoong Pharmaceutical Co. LTD. | 432 | 2020-09-11 | 2022-06-15 |
Pulmonary Disease, Chronic Obstructive (1) · Respiratory Aspiration (1)
AeroRx Therapeutics Inc. (1) · Daewoong Pharmaceutical Co. LTD. (1)
South Korea (1) · United Kingdom (1)
Dave Singh, MD (1)